RPS6KA3 gRNA (BRDN0001144943) Citations (1)
Originally described in: Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9.Doench JG, Fusi N, Sullender M, Hegde M, Vaimberg EW, Donovan KF, Smith I, Tothova Z, Wilen C, Orchard R, Virgin HW, Listgarten J, Root DE Nat Biotechnol. 2016 Jan 18. doi: 10.1038/nbt.3437. PubMed Journal
Articles Citing RPS6KA3 gRNA (BRDN0001144943)
| Articles |
|---|
| FLT3-ITD Activates RSK1 to Enhance Proliferation and Survival of AML Cells by Activating mTORC1 and eIF4B Cooperatively with PIM or PI3K and by Inhibiting Bad and BIM. Watanabe D, Nogami A, Okada K, Akiyama H, Umezawa Y, Miura O. Cancers (Basel). 2019 Nov 20;11(12). pii: cancers11121827. doi: 10.3390/cancers11121827. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.